Elon Musk wants to merge humans with AI. And his goal of achieving "symbiosis" with artificial intelligence starts with a ...

The recent acquisitions by pharmaceutical giants Johnson & Johnson and Bristol Myers Squibb, worth a combined $28billion, ...

Long waits for necessary care can add emotional distress during an already stressful time—plus, of course, open the door to ...

Technologies Corporation (NASDAQ:NMTC), a medical technology firm specializing in neurological surgical solutions with a market capitalization of $32 million, has recently announced it has met ...

Cognizant will continue to support key enterprise areas such as global finance systems and human capital management.

announced that it has unveiled its Neuro AI Multi-Agent Accelerator and Multi-Agent Service Suite, designed to accelerate the adoption of AI agents and transform business operations. These ...

Artedrone, a Truffle Capital's medtech portfolio company developing an autonomous micro robotic platform to perform and democratize mechanical thrombectomy procedures to treat patients suffering from ...

LONDON - IQ-AI Limited has shared a significant update on its operations, highlighting advancements in artificial ...

Thursday announced that it has expanded its long-standing collaboration with Gilead Sciences (GILD) to enhance cost ...

A new AI development framework and services are said to fast track multi-agent adoption by enabling interoperability and scalability to transform business processes.